Ikarian Capital, LLC Blueprint Medicines Corp Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $9.93 Million - $12.1 Million	-120,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $11 Million - $14.9 Million	120,000 New	120,000 $13.5 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $26.6 Million - $37.1 Million	-400,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $19.1 Million - $26.5 Million	334,000 Added 506.06%	400,000 $31.2 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $3.18 Million - $5.43 Million	66,000 New	66,000 $3.86 Million

352

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.76B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.